Nicotine patch, nicotine inhaler, bupropion + Nicotine patch
ApprovedCompleted 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Smoking Cessation
Conditions
Smoking Cessation
Trial Timeline
Sep 1, 2005 → Jan 1, 2008
NCT ID
NCT00770666About Nicotine patch, nicotine inhaler, bupropion + Nicotine patch
Nicotine patch, nicotine inhaler, bupropion + Nicotine patch is a approved stage product being developed by Johnson & Johnson for Smoking Cessation. The current trial status is completed. This product is registered under clinical trial identifier NCT00770666. Target conditions include Smoking Cessation.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00770666 | Approved | Completed |
Competing Products
20 competing products in Smoking Cessation